<DOC>
	<DOCNO>NCT02948231</DOCNO>
	<brief_summary>The Mistral investigational device intend percutaneous trans-catheter repair high risk surgery individual suffer functional Mitral Regurgitation . The device system use accordance approve Investigational Plan subject sign informed consent form . Device use limit approve study investigator .</brief_summary>
	<brief_title>MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study</brief_title>
	<detailed_description>The study design clinically demonstrate device acute safety ( Primary Endpoint ) along longer FU device safety effectiveness evaluation ( Secondary Endpoint ) . The main objective study : - Evaluate Acute safety implant Mistral device post procedure 30 day follow period . - Evaluate long term Safety device ( 3 6 month follow ) . - Demonstrate effectiveness Mistral device improve MR. Primary endpoint : • Safety : Acute safety . Rate device relate SAE include device relate mortality , stroke , MI , cardiac tamponade , surgery fail percutaneous repair non-elective cardiovascular surgery treat adverse event . At discharge 30 day . Secondary endpoint : - Safety : Safety 3 6 month . Rate device relate SAE 3 , 6 month . - Effectiveness : MR reduction post-procedure , discharge 30 day , 3 6 month . Improved NYHA class 6MWT distance 30 day , 3 6 month .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Subject willing able comply require followup evaluation Genders eligible study : Both gender Subject functional MR grade 3+ Subject leave ventricular ejection fraction ( LVEF ) &gt; 20 % &lt; 40 % . No contraindication transseptal puncture Subject functional class 3 ( NYHA ) The subject high risk undergo MV surgery . Subject exclude standard care procedure determine center heart team . Patients femoral vein enable catheterization 12Fr catheter Life expectancy ≥ 1 year Mitral Stenosis ≥ moderate Aortic Stenosis/Insufficiency &gt; moderate Subvalvular calcification calcification chordae . Subject prosthesis valve mitral/aortic position Subject history cerebral vascular accident ( CVA ) transient ischemic attack ( TIA ) within past 3 month . Subject history myocardial infarction ( MI ) past 3 month Subject refuse blood transfusion surgical valve replacement . Subject percutaneous interventional invasive cardiac peripheral procedure ≤ 7 day index procedure Subject history , active endocarditis Subject echocardiographic evidence intracardiac mass , thrombus , vegetation softmobile deposit Subject acute pulmonary edema . Subject hemodynamic instability require inotropic mechanical support . Subject know hypersensitivity contraindication anticoagulant antiplatelet medication Subject renal insufficiency evidence serum Creatinine &gt; 3.0mg/dL . Subject ongoing infection sepsis Subject blood dyscrasia ( leukopenia , acute anemia , thrombocytopenia , history bleeding diathesis , coagulopathy ) Subject active peptic ulcer gastrointestinal ( GI ) bleed within past 3 month prior index procedure Subject require emergency surgery reason Subject know allergy Nitinol alloy , 316L\304 stainless steel . Pregnant lactating woman . Patients dependent upon sponsor upon investigator upon investigational site . Subject know contrast medium allergy Presence high degree atrioventricular block ( 2nd 3rd degree AV block ) , presence trifascicular block According investigator site patient suffer severe end stage disease ( e.g . malignancy , severe pulmonary disease , liver disease , renal failure ) life expectancy le 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>